Amylyx Pharmaceuticals Statistics

Total Valuation

AMLX has a market cap or net worth of $740.09 million. The enterprise value is $565.23 million.

Market Cap	740.09M
Enterprise Value	565.23M

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

AMLX has 89.17 million shares outstanding. The number of shares has increased by 15.02% in one year.

Current Share Class	89.17M
Shares Outstanding	89.17M
Shares Change (YoY)	+15.02%
Shares Change (QoQ)	+4.02%
Owned by Insiders (%)	9.01%
Owned by Institutions (%)	66.67%
Float	47.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	-2,972.25
Forward PS	n/a
PB Ratio	4.41
P/TBV Ratio	4.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.72, with a Debt / Equity ratio of 0.04.

Current Ratio	8.72
Quick Ratio	8.45
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -87.42% and return on invested capital (ROIC) is -56.18%.

Return on Equity (ROE)	-87.42%
Return on Assets (ROA)	-46.74%
Return on Invested Capital (ROIC)	-56.18%
Return on Capital Employed (ROCE)	-113.74%
Revenue Per Employee	n/a
Profits Per Employee	-$1.53M
Employee Count	123
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-635,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +319.19% in the last 52 weeks. The beta is -0.45, so AMLX's price volatility has been lower than the market average.

Beta (5Y)	-0.45
52-Week Price Change	+319.19%
50-Day Moving Average	6.95
200-Day Moving Average	4.97
Relative Strength Index (RSI)	60.81
Average Volume (20 Days)	1,062,533

Short Selling Information

The latest short interest is 7.19 million, so 8.07% of the outstanding shares have been sold short.

Short Interest	7.19M
Short Previous Month	7.47M
Short % of Shares Out	8.07%
Short % of Float	15.02%
Short Ratio (days to cover)	4.53

Income Statement

In the last 12 months, AMLX had revenue of -$249,000 and -$187.60 million in losses. Loss per share was -$2.41.

Revenue	-249,000
Gross Profit	-94.52M
Operating Income	-196.98M
Pretax Income	-162.36M
Net Income	-187.60M
EBITDA	-196.30M
EBIT	-196.98M
Loss Per Share	-$2.41

Full Income Statement

Balance Sheet

The company has $180.83 million in cash and $5.96 million in debt, giving a net cash position of $174.86 million or $1.96 per share.

Cash & Cash Equivalents	180.83M
Total Debt	5.96M
Net Cash	174.86M
Net Cash Per Share	$1.96
Equity (Book Value)	167.88M
Book Value Per Share	1.88
Working Capital	165.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$165.65 million and capital expenditures -$36.23 million, giving a free cash flow of -$201.88 million.

Operating Cash Flow	-165.65M
Capital Expenditures	-36.23M
Free Cash Flow	-201.88M
FCF Per Share	-$2.26

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	79,106.43%
Pretax Margin	75,596.39%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AMLX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.02%
Shareholder Yield	-15.02%
Earnings Yield	-25.35%
FCF Yield	-27.28%

Dividend Details

Analyst Forecast

The average price target for AMLX is $12.00, which is 44.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	44.58%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	19.58%
EPS Growth Forecast (5Y)	-51.63%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AMLX has an Altman Z-Score of -0.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.67
Piotroski F-Score	3